Zydus Lifesciences wins USFDA nod for Chlorpromazine Hydrochloride Injection for certain mental disorders Susmita Roy14 March 2024 4:00 PM ISTThe drug will be manufactured at the group's injectable manufacturing facility at Jarod, near Vadodara (India).
CDSCO panel nod to Biological E to conduct Phase II trial of vaccine for 6- 8 weeks-old infants Anshika Mishra29 Jan 2024 5:24 PM ISTReviewing the Phase I clinical trial report, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation...
Health Bulletin 29/January/2024 Anshika Mishra29 Jan 2024 5:16 PM ISTHere are the top health news for the day:Three drug treatment regime to be introduced to stop leprosy transmission by 2027The Union Health Ministry...
Biological E gets CDSCO Panel Nod To study vaccine for 6- 8 weeks old infants Dr. Divya Colin28 Jan 2024 6:00 PM ISTNew Delhi: Reviewing the Phase I clinical trial report, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Revise Phase IV CT: CDSCO panel tells Bharat Biotech over Typhoid (Vi Capsular Polysaccharide) Tetanus Toxoid Conjugate Vaccine Dr. Divya Colin8 Nov 2023 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has directed the vaccine maker...
CDSCO panel grants GSK's proposal for Updation of Package Insert of Infanrix Hexa Vaccine Dr. Divya Colin22 March 2023 6:00 PM ISTNew Delhi: Pharmaceutical major GSK has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
CDSCO panel rejects Sanofi clinical study report on Hexavalent vaccine Dr. Divya Colin24 Sept 2022 6:00 PM ISTNew Delhi: Citing the clinical study report as not acceptable as presented, the Subject Expert Committee functional under the Central Drug Standard...
Serum Institute gets CDSCO Panel nod to manufacture Tdap vaccine for 4-55 year age group Dr. Divya Colin12 Sept 2022 6:00 PM ISTNew Delhi: Serum Institute of India has got a green signal from the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control...
CDSCO panel directs GSK to generate safety, immunogenicity data on Indian population for INFANRIX-IPV Dr. Divya Colin6 May 2022 7:06 PM ISTNew Delhi: Rejecting pharmaceuticals major GSK's proposal to import INFANRIX-IPV in the country without conducting a local clinical trial, the Subject...
Panacea Biotec gets CDSCO nod Pentavalent vaccine for 5 deadly disease Dr. Divya Colin1 March 2022 5:20 PM ISTNew Delhi: In a significant development, Panacea Biotec has got approval from the Subject Expert Committee (SEC) functional under the Central Drugs...
Patent Infringement: Panacea Biotec sues Sanofi in Delhi HC over pediatric vaccine medical dialogues team19 May 2021 2:40 PM ISTPunjab: In a major setback to Sanofi Healthcare India, Panacea Biotec has moved the Delhi High Court against the firm seeking to restrain it from...
Sanofi Pasteur unveils DTaP-IPV booster vaccine for preschoolers in India Ruchika Sharma2 Oct 2020 9:30 AM ISTNew Delhi: Sanofi Pasteur India, vaccine unit of pharma firm Sanofi, on Wednesday said it has launched a booster vaccine for preschoolers to protect...
